Post Approval Study of the CyPass System
Public ClinicalTrials.gov record NCT03273907. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Post Approval Study of the CyPass System in Patients With Primary Open Angle Glaucoma Undergoing Cataract Surgery
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to demonstrate that the rate of clinically relevant complications associated with CyPass Micro-Stent placement and stability using the CyPass 241-S applier, as determined at 36 months in the postmarket setting, is less than the pre-specified performance target, which is based on experience with the CyPass Model E applier in COMPASS trial TMI-09-01 (NCT01085357).
Study identification
- NCT ID
- NCT03273907
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 79 participants
Conditions and interventions
Conditions
Interventions
- CyPass Micro-Stent implanted with CyPass 241-S applier Device
- Cataract surgery Procedure
Device · Procedure
Eligibility (public fields only)
- Age range
- 45 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 12, 2017 (Actual)
- Primary completion
- Aug 31, 2021 (Actual)
- Completion
- Aug 31, 2021 (Actual)
- Last update posted
- Feb 16, 2024
2017 – 2021
United States locations
- U.S. sites
- 20
- U.S. states
- 13
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alcon Investigative Site | Phoenix | Arizona | 85016 | — |
| Alcon Investigative Site | Orange | California | 92868 | — |
| Alcon Investigative Site | Fort Collins | Colorado | 80528 | — |
| Alcon Investigative Site | Jacksonville | Florida | 32256 | — |
| Alcon Investigative Site | Panama City | Florida | 32405 | — |
| Alcon Investigative Site | Gainesville | Georgia | 30501 | — |
| Alcon Investigative Site | Marietta | Georgia | 30060 | — |
| Alcon Investigative Site | Garden City | Kansas | 67846 | — |
| Alcon Investigative Site | Fraser | Michigan | 48026 | — |
| Alcon Investigative Site | St Louis | Missouri | 63131 | — |
| Alcon Investivative Site | St Louis | Missouri | 63141 | — |
| Alcon Investigative Site | Vineland | New Jersey | 08361 | — |
| Alcon Investigative Site | Bala-Cynwyd | Pennsylvania | 19004 | — |
| Alcon Investigative Site | Chambersburg | Pennsylvania | 17201 | — |
| Alcon Investigative Site | Austin | Texas | 78731 | — |
| Alcon Investigative Site | El Paso | Texas | 79902 | — |
| Alcon Investigative Site | Houston | Texas | 77030 | — |
| Alcon Investigative Site | Bellevue | Washington | 98004-3012 | — |
| Alcon Investigative Site | Kenosha | Wisconsin | 53142 | — |
| Alcon Investigative Site | Racine | Wisconsin | 53405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03273907, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 16, 2024 · Synced Nov 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03273907 live on ClinicalTrials.gov.